Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Brazil Antitrust Regulator Blocks Amil, Health Deals, Folha Says

Oct. 26 (Bloomberg) -- Brazil’s antitrust regulator will put certain merger and acquisition deals in the health industry on hold because it’s concerned that purchases of hospitals, laboratories and smaller companies by health insurance firms are leading to too much market concentration, Folha de S.Paulo reported, without saying where it got the information.

The regulator, known as Cade, will block the merger of laboratory chain Diagnosticos da America SA and Amil Participacoes SA’s MD1 Diagnosticos SA until it has completed a final analysis of the transaction, according to the newspaper. Similar steps are being undertaken in relation to Amil’s planned acquisition of Medial Saude SA, Folha said.

Amil didn’t comment when contacted by Folha, according to the newspaper.

Link to Company News:{AMIL3 BZ <Equity> CN <GO>} Link to Company News:{DASA3 BZ <Equity> CN <GO>} Link to Company News:{MEDI3 BZ <Equity> CN <GO>}

To contact the reporter on this story: Karen Eeuwens in London at

To contact the editor responsible for this story: Telma Marotto at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.